Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Guido Tamburrano"'
Autor:
J.-L. Wémeau, Thierry Brue, Guido Tamburrano, Francesco Cavagnini, Vincent Rohmer, Enrica Ciccarelli, Philippe Lecomte, Bruno Estour, Piero Ferolla, Alain Calender, Brigitte Delemer, Achille Stevenaert, F. Archambeaud, F. Penfornis, Antonio Ciccarelli, Hernan Valdes-Socin, W. W. de Herder, A. Colao, Marie Lise Jaffrain-Rea, Philippe Emy, Arnaud Murat, Albert Beckers, Adrian Daly, C. Borson-Chazot, E. De Menis, Jérôme Bertherat
Publikováno v:
Journal of Clinical Endocrinology and Metabolism, 91(9), 3316-3323. Endocrine Society
CONTEXT: Familial pituitary adenomas occur rarely in the absence of multiple endocrine neoplasia type 1 (MEN1) and Carney complex (CNC). OBJECTIVE: Our objective was to characterize the clinical and genealogical features of non-MEN1/CNC familial isol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d714102a9a30c9be8a187642094a125
https://pure.eur.nl/en/publications/bc615b49-47d2-4501-8c0d-9796a33255ef
https://pure.eur.nl/en/publications/bc615b49-47d2-4501-8c0d-9796a33255ef
Publikováno v:
Digestive and Liver Disease. 36:S101-S105
The role of somatostatin and growth hormone in eye diseases recently became a matter of interest because of its link with proliferative diabetic retinopathy. In diabetic patients the pathologic proliferation of blood vessels as a result of retinal is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::288ed6c397b38cad59971f042378e06a
https://doi.org/10.1016/j.dld.2003.11.016
https://doi.org/10.1016/j.dld.2003.11.016
Autor:
Guido Tamburrano, Vincenzo Trischitta, Maria Cristina Ribaudo, Elisabetta Ferretti, Eugenio D'Amico, Antonio Liuzzi, Roberto Baratta, Maria Rosaria Ghiggi, Claudia Battista, Frida Leonetti, Antonella Paoloni, Roberto Baldelli
Publikováno v:
Clinical Endocrinology. 59:492-499
Summary objective Acromegaly is a syndrome with a high risk of impaired glucose tolerance (IGT) and diabetes mellitus (DM). Somatostatin analogues, which are used for medical treatment of acromegaly, may exert different hormonal effects on glucose ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f10a48ed8808035b77ceffc8aec2bd04
https://doi.org/10.1046/j.1365-2265.2003.01876.x
https://doi.org/10.1046/j.1365-2265.2003.01876.x
Autor:
L. Ausiello, Gianluca Aimaretti, Valentina Gasco, Guido Tamburrano, Cosimo Durante, Silvia Grottoli, C. Di Somma, Roberto Baldelli, G. Corneli, S. Rovere, Ezio Ghigo
Publikováno v:
Clinical Endocrinology. 59:56-61
Summary objective Within an appropriate clinical context, GH deficiency (GHD) in adults must be demonstrated biochemically by a single provocative test. Insulin-induced hypoglycaemia (ITT) and GH-releasing hormone (GHRH) + arginine (ARG) are indicate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3c0db583fcec469ff5a50113409bf14f
https://doi.org/10.1046/j.1365-2265.2003.01794.x
https://doi.org/10.1046/j.1365-2265.2003.01794.x
Autor:
Massimo Federici, Monica D’Adamo, Guido Tamburrano, A. Buongiorno, Davide Lauro, Nicola Di Daniele, Gianfranco Silecchia, Maria Sole Basso, Paolo Sbraccia, Frida Leonetti, Renato Lauro
Publikováno v:
Clinical Endocrinology. 57:199-207
OBJECTIVE To investigate whether skeletal muscle uncoupling protein-2 (UCP2) and uncoupling protein-3 (UCP3) gene expression is altered in massive obesity and whether it correlates with in vivo insulin sensitivity and with metabolic and hormonal stat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::03c421cc0d837a3d98d110319955d5c2
https://doi.org/10.1046/j.1365-2265.2002.01593.x
https://doi.org/10.1046/j.1365-2265.2002.01593.x
Publikováno v:
Pituitary. 5:27-31
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b984a405bd79431c9f84def1c7160fe
https://doi.org/10.1023/a:1022101417810
https://doi.org/10.1023/a:1022101417810
Autor:
Britt Skogseid, Cesare Bordi, John P. Bilezikian, Robert F. Gagel, Bruce A.J. Ponder, Samuel A. Wells, Stephen J. Marx, Norman W. Thompson, Bernard Conte-Devolx, Alberto Falchetti, Alfonso Libroia, Frank Raue, Furio Pacini, Rajesh V. Thakker, Alberto Angeli, Paolo Beck-Peccoz, Guido Tamburrano, Massimo Mannelli, Gaetano Lombardi, Cornelius J. M. Lips, Paola Tomassetti, R. G. Gheri, Francesco Tonelli, Maria Luisa Brandi
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 86:5658-5671
This is a consensus statement from an international group, mostly of clinical endocrinologists. MEN1 and MEN2 are hereditary cancer syndromes. The commonest tumors secrete PTH or gastrin in MEN1, and calcitonin or catecholamines in MEN2. Management s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06f64fd46b1500d974740f86031806f7
https://doi.org/10.1210/jcem.86.12.8070
https://doi.org/10.1210/jcem.86.12.8070
Autor:
Giuseppe Minniti, Antonio Santoro, C. Moroni, Giampaolo Cantore, Guido Tamburrano, Cesare Affricano, Vincenzo Esposito, Marie Lise Jaffrain-Rea, R. Cassone
Publikováno v:
Clinical Endocrinology. 55:307-313
OBJECTIVE Transsphenoidal surgery results in biochemical remission of acromegaly in 45–80% of patients; however, few studies have addressed the impact of transsphenoidal surgery on cardiovascular function in acromegalic patients. The aim of this pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::23c6e4fdb03da3897c251db191993409
https://doi.org/10.1046/j.1365-2265.2001.01343.x
https://doi.org/10.1046/j.1365-2265.2001.01343.x
Autor:
R. Cassone, Claudia Battista, Marie Lise Jaffrain-Rea, Nicola Sicolo, M. Correra, Roberto Baldelli, Pietro Maffei, Elisabetta Ferretti, Antonio Liuzzi, Maria Rosaria Ghiggi, Guido Tamburrano, Vincenzo Trischitta, C. Moroni, Alberto Angeli, Massimo Terzolo
Publikováno v:
Clinical Endocrinology. 54:189-195
BACKGROUND Hypertension represents a well-known risk factor for cardiovascular diseases. The pathogenesis of hypertension in acromegaly is commonly viewed as multifactorial, but the possible influence of metabolic disorders on blood pressure (BP) in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b6f69b92fe23d4835e5ccbe964357acd
https://doi.org/10.1046/j.1365-2265.2001.01206.x
https://doi.org/10.1046/j.1365-2265.2001.01206.x
Autor:
Diego Ferone, Guido Tamburrano, Roberto Baldelli, Elisabetta Ferretti, D. Gaia, Enrica Ciccarelli, Gaetano Lombardi, Franco Camanni, P. Razzore, Annamaria Colao, Paolo Marzullo, Marie Lise Jaffrain-Rea
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 85:4099-4103
Pharmacotherapy of acromegaly has been improved in recent years as new long-acting somatostatin analogs have became available; they have been suggested as an alternative treatment to pituitary surgery and radiotherapy. To avoid the inconvenience of m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2900f3771cca64b204ecdf6bd9020dd8
https://doi.org/10.1210/jcem.85.11.6948
https://doi.org/10.1210/jcem.85.11.6948